Ajanta Pharma

BSE : 532331 | NSE : AJANTPHARM

Industry : Pharma Formulations | ISIN : INE031B01049 | FreeFloat : 30.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)9,554.66
Net Worth (NW)3,264.35
Intrinsic Worth (IW)12,819.01
Market Cap (MC)15,466.66
Economic Value Added66.61
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)74.54%
IC Gross Margin (EBITDA/IC)11.89%
IC Net Margin (NPT/IC)8.05%
Knowledge Turnover (Sales/IC)0.37
Market to Intrinsic Value (MC/IW)1.21

As OfIntrinsic ValueMarket Price
31 Mar 2022Rs. 1,500.78Rs. 1,810.75
18 May 2022 ---- Rs. 1,702.70
-3.85     -0.23%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 1,705.97SellAvoid
KB > 50% : Yes50 DMA : Rs. 1,773.18
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-19
C
611.94
619.58
176.02
153.24
151.45
114.63
113.33
Sep-19
C
642.76
655.98
189.79
166.49
161.56
116.36
116.50
Dec-19
C
651.21
665.85
200.27
176.67
175.10
107.55
109.38
Mar-20
C
681.96
738.65
205.52
179.48
175.86
129.16
134.05
Jun-20
C
668.20
681.32
236.34
208.32
206.69
147.76
148.54
Sep-20
C
715.91
720.76
279.10
250.77
249.24
170.22
166.36
Dec-20
C
748.74
754.22
247.16
218.02
215.47
176.63
176.77
Mar-21
C
756.84
759.37
261.94
231.34
228.78
159.26
156.44
Jun-21
C
747.99
780.62
252.84
221.96
220.45
173.75
171.75
Sep-21
C
884.80
914.34
292.36
260.82
260.42
195.94
195.29
Dec-21
C
837.91
861.94
263.61
231.89
230.94
191.78
190.19
Mar-22
C
870.29
899.77
236.17
205.01
197.67
151.21
150.41
* C - Consolidated, S - Standalone